MC1R/MC4R binding and GPCR signaling pathways examined in receptor-pharmacology research.
Melanocortin receptor binding
Research with PT-141 centers on its binding to melanocortin receptors, particularly MC1R and MC4R. As a non-selective-leaning agonist it is used to probe receptor affinity and selectivity profiles in radioligand and fluorescence binding assays under controlled in-vitro conditions.
GPCR signaling
Because melanocortin receptors are G-protein-coupled, downstream readouts such as cAMP accumulation are common endpoints in studies using PT-141 as a reference agonist. These experiments characterize signaling efficacy and potency in recombinant cell systems.
Comparative pharmacology
PT-141 is frequently paired with related melanocortin peptides as a comparator, helping researchers map structure-activity relationships across the receptor family. All such work is reported as receptor-pharmacology characterization rather than any functional or physiological claim.
Evidence limits and research safety
Research findings can differ by model, assay, purity, formulation, and study design. Published cell, biochemical, and pre-clinical observations do not establish human or veterinary safety, efficacy, dosing, or suitability. Researchers should review the applicable SDS, institutional safety procedures, waste requirements, and lot-specific documentation before handling any reference material.
Related research
Explore the peptide collection